Skip to main content
Zaid Jabbar, MD, Internal Medicine, Oak Brook, IL, Edward Hospital

ZaidWaleedJabbarMDMS

Internal Medicine Oak Brook, IL

Bariatric Medicine, Obesity Medicine & Nutrition

President of Illinois Obesity Society, Department Lead Physician, Obesity Medicine at Duly Health and Care.

Dr. Jabbar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Jabbar's full profile

Already have an account?

Summary

  • Dr. Zaid Jabbar is an internist in Oak Brook, IL and is affiliated with multiple hospitals in the area, including Edward Hospital and Edward Hines, Jr. Veterans Affairs Hospital. He received his medical degree from University of Wisconsin School of Medicine and Public Health and has been in practice 12 years. He also speaks multiple languages, including Arabic. He specializes in obesity and weight management (primary care) and is experienced in metabolic syndrome, diabetes mellitus, obesity and obesity-related disorders, lipid metabolism disorders, and public speaking.

Education & Training

  • Loyola University Medical Center
    Loyola University Medical CenterResidency, Internal Medicine, 2005 - 2008
  • University of Wisconsin School of Medicine & Public Health
    University of Wisconsin School of Medicine & Public HealthClass of 2005

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2005 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Obesity Medicine Obesity Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

Journal Articles

  • Safety and Mode of Action of Diabetes Medications in comparison with 5-Aminolevulinic Acid (5-ALA)  
    Peter R. Rehani,1 Hanaa Iftikhar,2 Motowo Nakajima,3 Tohru Tanaka,3 Zaid Jabbar,4 and Riyadh N. Rehani5, Journal of Diabetes Research, 11/6/2019

Authored Content

  • Safety and Mode of Action of Diabetes Medications in comparison with 5-Aminolevulinic Acid (5-ALA)November 2019

Press Mentions

  • A New Genetic Test Could Determine Which Weight Loss Drug Will Actually Work for You
    A New Genetic Test Could Determine Which Weight Loss Drug Will Actually Work for YouJuly 1st, 2023

Professional Memberships

Other Languages

  • Arabic

Hospital Affiliations